Short answer: NHS esters mainly react with primary amines on proteins; maleimides mainly react with free thiols. For a conventional antibody, consider the NHS route first. Before choosing maleimide, establish whether free thiols are available and whether reduction is needed, then verify antibody function after labeling.
How the two labeling routes differ
| Comparison | NHS ester | Maleimide |
|---|---|---|
| Main reactive groups | Primary amines on lysine side chains and the protein N-terminus | Free thiols, such as those provided by cysteine |
| Sample preparation priorities | Protein purity and amine-containing additives | Available thiols and residual reducing agents |
| Typical reaction conditions | Mildly alkaline; follow the specific reagent's instructions | Near neutral; follow the specific reagent's instructions |
| Results to verify | Degree of labeling, purification and antibody function | Degree of labeling, purification and antibody function |
NHS esters form amide bonds with primary amines; maleimides form thioether linkages with thiols. NHS and maleimide derivatives of the same fluorophore require their own protocols, even when their fluorescence colors are similar.
When to consider an NHS ester first
For a conventional unlabeled IgG intended for flow cytometry or immunofluorescence, the NHS route is a starting point when there is no defined site requirement and no validated thiol preparation method. Qihe's AF dye series includes corresponding reactive derivatives, such as AF488 NHS.
Review the storage formulation before labeling. Primary amine-containing components such as Tris and glycine compete for amine-reactive dyes. Raising the pH alone does not remove this interference. Exchange the sample into a suitable reaction buffer when needed, then determine the pH, reagent input and incubation time from the purchased dye's instructions.
Antibodies formulated with BSA or gelatin require separate assessment because these proteins also participate in NHS labeling. Routine dialysis or common ultrafiltration buffer exchange should not be treated as reliable methods for removing BSA or gelatin. Prefer a carrier-free antibody or a purification method suitable for the specific antibody. Additive tolerance claimed for a dedicated labeling kit applies only within that kit's instructions; it cannot be assumed for a separately supplied NHS dye.
When to consider maleimide
Consider maleimide when the protein has accessible free thiols or a controlled thiol preparation method is available. It is also a route to evaluate when amine labeling affects antibody binding. See Qihe's AF488 Maleimide for a corresponding reagent.
Having cysteine residues does not necessarily mean the protein already has free thiols available for conjugation. Cysteines involved in disulfide bonds are not equivalent to available thiols. When reduction is required, choose the treatment and subsequent quality checks for the particular antibody and reagent. Do not simply increase reduction strength to obtain more labeling.
Thiol-containing reducing agents such as DTT compete with maleimide reagents and generally need to be removed before conjugation. For TCEP, follow the purchased reagent's specific protocol to determine the conditions and whether removal is required. Compatibility established for one formulation should not be generalized to every dye.
Four pieces of information to provide before choosing
- Sample identity: antibody clone, species and isotype, or protein name and whether free thiols are available.
- Storage formulation: buffer system, pH, and the identities and concentrations of BSA, gelatin, glycine, Tris, glycerol and reducing agents.
- Available sample: antibody concentration, total volume and amount, and acceptable losses during purification or buffer exchange.
- Intended application: flow cytometry, imaging or another assay; instrument channels, target dye and the function that must be retained.
When the sample is well characterized and purification, absorbance measurements and functional validation are available, a small-scale labeling experiment can be planned. For precious samples, complex formulations or an unestablished workflow, share this information with Qihe's technical team to discuss suitable dyes and labeling strategies. The labeling services page introduces available project types; sample acceptance and delivery criteria must be confirmed for each project.
Frequently asked questions
Does maleimide automatically provide single-site labeling?
The reactive group alone does not establish this. Maleimide targets thiols, but their available number and positions depend on the protein and its preparation. Single-site labeling requires a defined site strategy and product verification.
Will switching to maleimide guarantee retained antibody function?
No such guarantee can be made in advance. Compare binding before and after labeling, and assess whether sample treatment, degree of labeling and purification are appropriate for the intended assay.
Does a tenfold molar dye input mean ten dyes will bind to each antibody?
The input molar ratio and measured degree of labeling are different quantities. Degree of labeling, or DOL, is the average number of dyes bound per protein molecule and should be measured after free dye has been removed. The protein labeling calculator provides separate tools for reagent input and measured DOL; obtain the required parameters from the specific protein or dye instructions, or the CoA.
Should green-channel dyes also be compared?
Read the comparison of FITC, Alexa Fluor 488 and SF488, assess the instrument and assay conditions, then choose the required reactive derivative.
This article provides selection guidance for in vitro research. Follow the purchased product's instructions and sample validation results for the actual procedure.